Study to Assess Absolute Bioavailability of TAK-935 (OV935) and to Characterize Mass Balance, Pharmacokinetics, Metabolism, and Excretion of [14C]TAK-935 (OV935) in Healthy Male Participants
Clinical trial NCT04992442 · COMPLETED
Trial details
- NCT number
- NCT04992442
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-09
- Primary completion
- 2020-08-18
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.